Why Include the Public in Genome Editing Governance Deliberation?
- PMID: 31876471
- DOI: 10.1001/amajethics.2019.1065
Why Include the Public in Genome Editing Governance Deliberation?
Abstract
With the birth of genetically engineered twins in November 2018, international debate about human genome editing governance has moved from an emphasis on mutual engagement among multiple stakeholders to a self-regulatory model enacted through high-level expert groups with little or no public input. This article reconstructs this paradigm shift and suggests that inclusive public deliberation should still have a role in public decision making about genome editing.
© 2019 American Medical Association. All Rights Reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
